Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen

Journal of Immunology

Volumn 174, Issue 11, 2005, Pages 6772-6780

  Yu, Ping ^a   Gregg, Kandal K ^a,d   Bell, J Jeremiah ^a   Ellis, Jason S ^a   Divekar, Rohit ^a   Lee, Hyun Hee ^a   Jain, Renu ^a   Waldner, Hanspeter ^c   Hardaway, John C ^a   Collins, Mary ^b   Kuchroo, Vijay K ^c   Zaghouani, Habib ^a  

^a University of Missouri   (United States)

^b PFIZER INC   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AUTOANTIGEN; CHIMERIC PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN PROTEOLIPID PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEOLIPID PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CELL FUNCTION; CELL SPECIFICITY; CELL TRANSFER; CONTROLLED STUDY; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 21044453903     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.11.6772     Document Type: Article

References (42)

1. + suppressor T cells: more questions than answers. Nat Rev. Immunol. 2: 389-400.
2. + regulatory T cells for immunologic self-tolerance and negative control of immune response. Annu. Rev. Immunol. 22: 531-562.
3. von Herrath, M. G., and L. L. Harrison. 2003. Antigen-induced regulatory T cells in autoimmunity. Nat. Rev. Immunol. 3: 223-232.
4. Bluestone, J. A., and A. K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3: 253-257.
5. O'Garra, A., and P. Vieira. 2004. Regulatory T cells and mechanisms of immune system control. Nat. Med. 10: 801-805.
6. + regulatory T cells. J. Immunol. 170: 3939-3943.
7. Madakamutil, L. T., I. Maricic, E. Sercarz, and V. Kumar. 2003. Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes. J. Immunol. 170: 2985-2992.
8. Ehrenstein, M. R., J. G. Evans, A. Singh, S. Moore, G. Warnes, D. A. Isenberg, and C. Mauri. 2004. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF-α therapy. J. Immunol. 200: 277-285.
9. Tang, Q., K. J. Henriksen, M. Bi, E. B. Finger, G. Szot, J. Ye, E. L. Masteller, H. McDevitt, M. Bonyhadi, and J. A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199: 1455-1465.
10. + regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 101: 15434-15439.
11. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195:603-616.
12. 3 analog enhances regulatory cells and arrests autoimmune diabetes in NOD mice. Diabetes 51: 1367-1374.
13. + regulatory T cells. J. Immunol. 172: 5986-5993.
14. + regulatory T cell compartment. J. Immunol. 173: 2227-2230.
15. Belghith, M., J. A. Bluestone, S. Barriot, J. Megret, J. Bach, and L. Chatenoud. 2003. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 9: 1202-1208.
16. Legge, K. L., B. Min, N. T. Potter, and H. Zaghouani. 1997. Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processing. J. Exp. Med. 185: 1043-1053.
17. Legge, K. L., B. Min, J., J. Bell, J. C. Caprio, L. Li, R. K. Gregg, and H. Zaghouani. 2000. Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis. J. Exp. Med. 191: 2039-2052.
18. Legge, K. L., J. J. Bell, L. Li, R. K. Gregg, J. C. Caprio, and H. Zaghouani. 2001. Multi-modal antigen specific therapy for autoimmunity. Int. Rev. Immunol. 20: 593-611.
19. + T cell subset inhibits antigen-specific T cells responses and prevent colitis. Nature 389: 737-742.
20. Wakkach, A., N. Fournier, V. Brun, J. P. Breitmayer, F. Cottrez, and H. Groux. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605-617.
21. Waldner, H., M. J. Whitters, R. A. Sobel, M. Collins, and V. K. Kuchroo. 2000. Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor. Proc. Natl. Acad. Sci. USA 97: 3412-3417.
22. Waldner, H., M. Collins, and V. K. Kuchroo. 2004. Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J. Clin. Invest. 113: 990-997.
23. Tuohy, V. K., Z. Lu, R. A. Sobel, R. A. Laursen, and M. B. Lees. 1989. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142: 1523-1527.
24. Greer, J. M., V. K. Kuchroo, R. A. Sobel, and M. B. Lees. 1992. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J. Immunol. 149: 783-788.
25. Brocke, S., K. Gijbels, M. Allegretta, I. Ferber, C. Piercy, T. Blankenstein, R. Martin, U. Utz, N. Karin, D. Mitchell, et al. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. [Published erratum in 1998 Nature 392: 630.] Nature 379: 343-346.
26. Bernard, C. C. A., T. G. Johns, A. Slavin, M. Ichikawa, C. Ewing, J. Lui, and J. Bettadapura. 1997. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J. Mol. Med. 75: 77-88.
27. Min, B., K. L. Legge, C. Pack, and H. Zaghouani. 1998. Neonatal exposure to a self-peptide-immunoglobulin chimera circumvents the use of adjuvant and confers resistance to autoimmune disease by a novel mechanism involving interleukin 4 lymph node deviation and Interferon γ-mediated splenic anergy. J. Exp. Med. 188: 2007-2017.
28. Pack, C. D., A. E. Cestra, M. Booki, K. L. Legge, L. Li, J. C. Caprio-Young, J. J. Bell, R. K. Gregg, and H. Zaghouani. 2001. Neonatal exposure to antigen primes the immune system to develop responses in various Iymphoid organs and promotes bystander regulation of diverse T cell specificities. J. Immunol. 167: 4187-4195.
29. Legge, K. L., R. K. Gregg, R. Maldonado-Lopez, L. Li, J. C. Caprio, M. Moser, and H. Zaghouani. 2002. On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J. Exp. Med. 196: 217-227.
30. Li, L., H.-H. Lee, J. J. Bell, R. K. Gregg, J. S. Ellis, A. Gessner, and H. Zaghouani. 2004. IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity towards Th2. Immunity 20: 429-440.
31. + regulatory T cells. Nat. Immunol. 4: 330-336.
32. Lehmann, P. V., T. Forsthuber, A. Miller, and E. E. Sercarz. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358: 155-157.
33. Yu, M., J. M. Johnson, and V. K. Tuohy. 1996. Predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183: 1777-1788.
34. + T cell suppressor function. Eur. J. Immunol. 34: 366-376.
35. Chen, T. C., S. P. Cobbold, P. J. Fairchild, and H. Waldman. 2004. Generation of anergic and regulatory T cells following prolonged exposure to a harmless antigen. J. Immunol. 172: 5900-5907.
36. + T cells expressing membrane-bound TGB-β and Foxp3. J. Clin. Invest 114: 28-38.
37. + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Nat Acad. Sci. USA 99: 8213-8218.
38. Tanchot, C., F. Vasseur, C. Pontoux, C. Garcia, and A. Sarukhan. 2004. Immune regulation by self-reactive T cells is antigen specific. J. Immunol. 172: 4285-4291.
39. + T regulatory cells on development, functional activation, and proliferation of Th2 cells. J. Immunol. 173: 267-274.
40. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199: 1467-1477.
41. Gregg, R. K., R. Jain, S. J. Schoenleber, R. Divekar, J. J. Bell, H.-H. Lee, P. Yu, and H. Zaghouani. 2004. A sudden decline in active membrane-bound TGF-β impairs both Treg function and protection against autoimmune diabetes. J. Immunol. 173: 7308-7316.
42. Gregg, R. K., J. J. Bell, H.-H. Lee, R. Jain, S. J. Schoenleber, R. Divekar, and H. Zaghouani. 2005. Interlukin-10 diminishes CTLA-4 expression on islet-resident T cells and sustains their activation rather than tolerance. J. Immunol. 174: 662-670.